Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2014-07-16
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 11
- Registration Number
- NCT01078922
- Locations
- 🇺🇸
Oncology Specialists, S.C., Park Ridge, Illinois, United States
🇺🇸Oncology Specialists, S.C, Niles, Illinois, United States
🇺🇸University of Illinois at Chicago, Chicago, Illinois, United States
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2014-06-30
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 21
- Registration Number
- NCT00919035
- Locations
- 🇺🇸
Oncology Specialists, S.C., Park Ridge, Illinois, United States
🇺🇸Oncology Specialists, SC, Niles, Illinois, United States
Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
- Conditions
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2014-07-01
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 50
- Registration Number
- NCT00902434
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2014-03-28
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 32
- Registration Number
- NCT00654186
- Locations
- 🇺🇸
Oncology Specialists, S.C, Park Ridge, Illinois, United States
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
- First Posted Date
- 2007-01-19
- Last Posted Date
- 2014-07-21
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 17
- Registration Number
- NCT00424385
- Locations
- 🇺🇸
Oncology Specialists, S.C, Park Ridge, Illinois, United States
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2014-04-07
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 22
- Registration Number
- NCT00414388
- Locations
- 🇺🇸
Onocology Specialists, S.C, Niles, Illinois, United States
🇺🇸Oncology Specialists, S.C, Park Ridge, Illinois, United States
VELCADE,Rituximab,Cyclophosphamide and Decadron
- Conditions
- Interventions
- First Posted Date
- 2006-12-20
- Last Posted Date
- 2018-09-19
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 12
- Registration Number
- NCT00413959
- Locations
- 🇺🇸
Onocology Specialists, S.C, Niles, Illinois, United States
🇺🇸Oncology Specialists, S.C, Park Ridge, Illinois, United States
GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 15
- Registration Number
- NCT00274287
- Locations
- 🇺🇸
Oncology Specialists, SC, Park Ridge, Illinois, United States
Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer
- First Posted Date
- 2006-01-04
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 29
- Registration Number
- NCT00272038
- Locations
- 🇺🇸
Oncology Specialists, SC, Park Ridge, Illinois, United States
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2017-11-29
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 33
- Registration Number
- NCT00156013
- Locations
- 🇺🇸
Oncology Specialists, SC, Park Ridge, Illinois, United States